Ares Capital Stock Down 6% in a Month: Time to Buy the Dip or Wait?

24.03.25 15:53 Uhr

Werte in diesem Artikel
Aktien

20,51 EUR -0,05 EUR -0,22%

Ares Capital Corporation ARCC stock has not been able to remain immune to the recent broader market decline. In the past month, it has lost 6%. The stock has underperformed the industry and the Zacks Finance industry. Nonetheless, the stock has fared better than its peers, such as Amalgamated Financial Corp. AMAL and Hercules Capital, Inc. HTGC.ARCC’s One-Month Price PerformanceImage Source: Zacks Investment ResearchThe recent market slump was primarily driven by the ongoing tariff war, as President Trump’s tariffs have led to retaliation, igniting concerns regarding a full-scale trade war. Also, economic data indicates a slowdown in the U.S. Inflationary pressure has also remained elevated. These factors resulted in ambiguity and fear in the market, exacerbating the downturn.Given the uncertain and volatile backdrop, let us decipher whether ARCC stock is worth adding to your portfolio.Factors to Support Ares Capital’s StockRising Investment Commitments to Aid Investment Income: Ares Capital has been witnessing growth in its total investment income over the years. While the metric declined in 2020, it witnessed a five-year (2019-2024) compound annual growth rate (CAGR) of 14.4%. The rise has been primarily driven by an increase in demand for personalized financing solutions, leading to higher investment commitments.Revenue TrendImage Source: Zacks Investment ResearchIn 2024, 2023, 2022, 2021, 2020 and 2019, the company originated $15.1 billion, $6 billion, $9.9 billion, $15.6 billion, $6.7 billion and $7.3 billion, respectively, in gross investment commitments to new and existing portfolio companies. Moreover, from Jan. 1, 2025, to Jan. 28, 2025, the company made new investment commitments worth roughly $1.2 billion, of which roughly $864 million was funded. As of Dec. 31, 2024, ARCC had a diversified investment portfolio of $26.7 billion across 550 portfolio companies, thus reducing concentration risk and adding sustainability to the total investment income. It had 24.5% of its investment portfolio in software & services and 12% in healthcare equipment & services. Other major investment areas were commercial & professional services (9.4%), financial services (9.9%) and insurance services (5.9%).Investment PortfolioImage Source: Ares Capital Corp.ARCC’s total investment income is likely to grow on the back of relatively lower interest rates, driving higher demand for customized financing, a diverse investment portfolio and a steady rise in investment commitments.Sales EstimatesImage Source: Zacks Investment ResearchImpressive Capital Distributions: As of Dec. 31, 2024, Ares Capital had a debt of $13.7 billion, while cash and cash equivalents (including restricted cash) were $860 million. Additionally, the company has a revolving credit facility, enabling the company to borrow up to $4.5 million whenever required.Given a decent balance sheet position, the company has been engaging in capital distribution activities. ARCC distributed 90% of its taxable income as dividends to maintain its regulated investment company (RIC) status. The company last hiked its dividends in 2022 by 11.6% to 48 cents per share. The company has increased its dividend four times in the last five years with an annualized dividend growth of 5.45%. Its dividend payout ratio is 82%.Dividend YieldImage Source: Zacks Investment ResearchSimilarly, AMAL has increased its dividends thrice in the last five years, while HTGC has increased it nine times during the same period.ARCC also has an ongoing repurchase plan. This February, it announced an extension of its existing share repurchase authorization of $1 billion, set to expire on Feb. 15, 2026.Bearish Analyst Sentiments for ARCC StockOver the past week, the Zacks Consensus Estimate for 2025 and 2026 earnings of $2.18 and $2.16, respectively, has been revised marginally downward.Estimate Revision TrendImage Source: Zacks Investment ResearchThe projected figures imply a decline of 6.4% and 1.1% for 2025 and 2026, respectively.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.To Buy or Not to Buy Ares Capital Stock NowAres Capital is well-positioned for growth, given the demand for customized financing, relatively lower rates, and a diversified investment portfolio. Also, a decent liquidity position is a tailwind.However, a steady rise in expenses is a headwind. Although expenses dipped in 2020 and 2022, the company recorded a five-year CAGR of 16.6% (ended 2024) due to higher interest and credit facility fees and income-based fees. Overall expenses are expected to be elevated in the near term due to the company’s expansion efforts.Expense TrendImage Source: Zacks Investment ResearchIn terms of valuation, Ares Capital’s price-to-book ratio (P/B) of 1.09X is higher than the industry's 0.96X. Thus, the stock is trading at a premium. This suggests that investors may pay a higher price than the company's expected earnings growth.P/B RatioImage Source: Zacks Investment ResearchFurther, bearish analyst sentiments are a headwind.Thus, investors should watch out for these concerns and monitor how Ares Capital navigates the current operating backdrop and generates solid investment income. Those who already own the stock can hold on to it for robust long-term gains.Currently, ARCC carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.7 Best Stocks for the Next 30 DaysJust released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.3% per year. So be sure to give these hand picked 7 your immediate attention. See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Ares Capital Corporation (ARCC): Free Stock Analysis Report Hercules Capital, Inc. (HTGC): Free Stock Analysis Report Amalgamated Financial Corp. (AMAL): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Ares Capital und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Ares Capital

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Ares Capital

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Ares Capital CorpShs

Wer­bung

Analysen zu Ares Capital CorpShs

DatumRatingAnalyst
23.08.2019Ares Capital NeutralCompass Point
19.08.2019Ares Capital OutperformBMO Capital Markets
21.09.2017Ares Capital OutperformOppenheimer & Co. Inc.
28.06.2016Ares Capital NeutralNational Securities
25.02.2016Ares Capital OverweightBarclays Capital
DatumRatingAnalyst
19.08.2019Ares Capital OutperformBMO Capital Markets
21.09.2017Ares Capital OutperformOppenheimer & Co. Inc.
25.02.2016Ares Capital OverweightBarclays Capital
30.09.2015Ares Capital BuyD.A. Davidson & Co.
13.02.2015Ares Capital Market PerformBMO Capital Markets
DatumRatingAnalyst
23.08.2019Ares Capital NeutralCompass Point
28.06.2016Ares Capital NeutralNational Securities
05.05.2015Ares Capital HoldBB&T Capital Markets
20.08.2009Allied Capital market performKeefe, Bruyette & Woods, Inc.
06.02.2007Update Allied Capital Corp.: HoldAG Edwards
DatumRatingAnalyst
06.12.2005Update Allied Capital Corp.: UnderperformHarris Nesbitt

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Ares Capital CorpShs nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen